Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Great Tree Pharmacy CoROCO:6469 +1.56%69 ROC (Joel Greenblatt) % is 9.55% as of Mar. 2026, which is 39% below its 10-year median of 15.65. GuruFocus rates ROCO:6469 with a GF Score™ of 69/100 and a GF Value™ of NT$178.40 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Great Tree Pharmacy Co ranks worse than 52.78% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Great Tree Pharmacy Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 9.55%.
The historical rank and industry rank for Great Tree Pharmacy Co's ROC (Joel Greenblatt) % or its related term are showing as below:
ROCO:6469'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 7.74 Med: 15.65 Max: 20.91
Current: 11.04
During the past 13 years, Great Tree Pharmacy Co's highest ROC (Joel Greenblatt) % was 20.91%. The lowest was 7.74%. And the median was 15.65%.
ROCO:6469's ROC (Joel Greenblatt) % is ranked worse than 52.78% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 12.49
vs ROCO:6469: 11.04
Great Tree Pharmacy Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 6.70% per year.
Great Tree Pharmacy Co (ROCO:6469) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Great Tree Pharmacy Co ROC (Joel Greenblatt) % Related Terms
Great Tree Pharmacy Co ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Great Tree Pharmacy Co's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Great Tree Pharmacy Co ROC (Joel Greenblatt) % Chart
Great Tree Pharmacy Co ROC (Joel Greenblatt) % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Great Tree Pharmacy Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Great Tree Pharmacy Co ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Great Tree Pharmacy Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Great Tree Pharmacy Co's ROC (Joel Greenblatt) % falls into.
Great Tree Pharmacy Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 9.55% mean?
Great Tree Pharmacy Co (ROCO:6469) has a ROC (Joel Greenblatt) % of 9.55% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Great Tree Pharmacy Co and its competitors. This is 39% below median its historical median of 15.65. Over the past decade, Great Tree Pharmacy Co's ROC (Joel Greenblatt) % has ranged from 7.74 to 20.91. According to the industry distribution chart, Great Tree Pharmacy Co ranks #351 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 52.8%.
Is Great Tree Pharmacy Co's ROC (Joel Greenblatt) % too high?
Great Tree Pharmacy Co's current ROC (Joel Greenblatt) % of 9.55% is 39% below median its 10-year median of 15.65. Over the past 10 years, this metric has ranged from a low of 7.74 to a high of 20.91. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.49. Great Tree Pharmacy Co's value of 9.55% is 23.5% below this industry median. Based on the distribution chart, Great Tree Pharmacy Co ranks #351 out of 665 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Great Tree Pharmacy Co has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Great Tree Pharmacy Co's ROC (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Great Tree Pharmacy Co ranks #351 out of 665 companies for ROC (Joel Greenblatt) %. This places Great Tree Pharmacy Co in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 12.49. Great Tree Pharmacy Co's value of 9.55% is 23.5% below this benchmark. Historically, Great Tree Pharmacy Co's own ROC (Joel Greenblatt) % has ranged from 7.74 to 20.91 over the past decade. While the company's 10-year median is 15.65 vs. the industry median of 12.49, Great Tree Pharmacy Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.49, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Great Tree Pharmacy Co's current ROC (Joel Greenblatt) % of 9.55% is 23.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Great Tree Pharmacy Co and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Great Tree Pharmacy Co's current ROC (Joel Greenblatt) % is 9.55%, which is 39% below median its own 10-year median of 15.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Great Tree Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Great Tree Pharmacy Co (ROCO:6469) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$178.40, compared to a current price of NT$78.20 — trading 56.2% below its estimated fair value. The current ROC (Joel Greenblatt) % is 9.55%, which is 39% below median its 10-year median of 15.65 and 23.5% below the Healthcare Providers & Services industry median of 12.49. Great Tree Pharmacy Co's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Great Tree Pharmacy Co (ROCO:6469), the current ROC (Joel Greenblatt) % is 9.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Great Tree Pharmacy Co (ROCO:6469) Overvalued in 2026?
Based on GuruFocus' analysis, Great Tree Pharmacy Co stock appears to be undervalued.
The current stock price of NT$78.20 is trading 56.2% below its estimated GF Value™ of NT$178.40.
GuruFocus considers Great Tree Pharmacy Co to be Significantly Undervalued.
Key valuation signals for ROCO:6469:
ROC (Joel Greenblatt) %: 9.55% (39% below median its 10-year median of 15.65)
GF Value™: NT$178.40 vs. price of NT$78.20 (56.2% below fair value)
Industry Position: 23.5% below the Healthcare Providers & Services median (#351 of 665)
No single metric tells the full story. See the ROCO:6469 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Great Tree Pharmacy Co Ltd engages in management and trading of various drugs, health supplements, maternity and infant products, and cosmetics products. It also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, it is also an agency for domestic and foreign health care products sold in clinics, outpatient centers, and medical communities. Its products include infant formula, baby diapers, Maternal and Infant Related, Adult drinks, Nutrition and health care, Body care, Daily Necessities, medical equipment, and Pet products.
69GF Score
Get the complete analysis for ROCO:6469
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6469 has been successfully added to your 
